FDA Adverse Event Injury Summary report: N

ANGIOGUARD RX EMBOLI CAPTURE GUIDEWIRE SYSTEM

MDR report key: 3574468 · Received January 14, 2014

Report

Report Number
1016427-2014-00007
Event Type
Injury
Date Received
January 14, 2014
Date of Event
October 31, 2013
Report Date
December 9, 2013
Manufacturer
CORDIS CORPORATION
Product Code
NTE
PMA / PMN Number
K062531
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AZ
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

CONCLUSION: AS REPORTED BY THE (B)(4) THE PRECISE PRO RX US CAROTID SYSTEM FAILED TO CROSS THE LESION. IT WAS ALSO NOTED THAT A GRADE B DISSECTION OCCURRED AT THE LESION, DURING PRE-DILATION. THE DISSECTION WAS COVERED AND TREATED BY THE PRECISE STENT WHICH WAS PLACED AT ITS INTENDED LOCATION. THE PATIENT IS AN (B)(4) YEAR-OLD MALE. THE TARGET LESION LOCATION WAS THE OSTIUM OF THE LEFT INTERNAL CAROTID ARTERY. THE VESSEL WAS DESCRIBED AS SEVERELY CALCIFIED AND MILDLY TORTUOUS. THE RATE OF STENOSIS WAS 90%. AN ANGIOGUARD (801814REC/ LOT 7071244) EMBOLIC PROTECTION DEVICE WAS ADVANCED AND DEPLOYED DISTAL TO THE LESION. THE LESION WAS PRE-DILATED WITH AN AVIATOR (5 X 30) BALLOON. DURING PRE-DILATION A GRADE B DISSECTION WAS NOTED AT THE LESION. THE PHYSICIAN ATTEMPTED TO PLACE A PRECISE STENT IN THE LESION, BUT IT WOULD NOT CROSS. THEREFORE THE PRECISE WAS REMOVED AND ANOTHER PRECISE STENT WAS PLACED AND THE LESION WAS SUCCESSFULLY TREATED. THERE WAS NO REPORTED INJURY TO THE PATIENT. THE PATIENT WAS DISCHARGED THE NEXT DAY. THE PRODUCT WAS NOT RETURNED FOR EVALUATION AND TESTING. A REVIEW OF THE MANUFACTURING DOCUMENTATION ASSOCIATED WITH THIS LOT PRESENTED NO ISSUES DURING THE MANUFACTURING PROCESS THAT CAN BE RELATED TO THE REPORTED COMPLAINT. VESSEL DISSECTION IS A KNOWN PROCEDURAL COMPLICATION AND AN INHERENT RISK OF THIS TYPE OF PROCEDURE AND DOES NOT REPRESENT DEVICE MALFUNCTION. VESSEL CHARACTERISTICS AND/OR PROCEDURAL FACTORS (SUCH AS WIRE MANIPULATION AND PRE-DILATION OF THE VESSEL WALL) MAY CONTRIBUTE TO DISSECTION. THERE IS NO EVIDENCE TO SUGGEST THAT THIS EVENT IS RELATED TO A MANUFACTURING ISSUE OR ANY DEFECT OF THE DEVICE. THE EXACT CAUSE OF THE REPORTED FAILURE TO CROSS COULD NOT BE DETERMINED, BUT PATIENT AND PROCEDURAL FACTORS MAY HAVE CONTRIBUTED TO THIS EVENT. DHR REVIEW CONFIRMED THAT THE PRODUCT MET SPECIFICATIONS. NEITHER THE DHR NOR THE INFORMATION AVAILABLE FOR REVIEW INDICATE THAT THERE IS A DESIGN OR MANUFACTURING RELATED ISSUE, THEREFORE NO CORRECTIVE ACTION IS REQUIRED. PLEASE NOTE THAT THIS MEDWATCH REPORT REPRESENTS ONE OF TWO PRODUCTS INVOLVED WITH THIS EVENT WHICH IS ASSOCIATED WITH MFG. REPORT # 1016427-2014-00007 AND 9616099-2014-00036.

Description of Event or Problem · 1

AS REPORTED BY THE (B)(4) THE PRECISE PRO RX US CAROTID SYSTEM FAILED TO CROSS THE LESION. IT WAS ALSO NOTED THAT A GRADE B DISSECTION OCCURRED AT THE LESION, DURING PRE-DILATION. THE DISSECTION WAS COVERED AND TREATED BY THE PRECISE STENT WHICH WAS PLACED AT ITS INTENDED LOCATION. THE PATIENT IS AN (B)(6) YEAR-OLD MALE. THE TARGET LESION LOCATION WAS THE OSTIUM OF THE LEFT INTERNAL CAROTID ARTERY. THE VESSEL WAS DESCRIBED AS SEVERELY CALCIFIED AND MILDLY TORTUOUS. THE RATE OF STENOSIS WAS 90%. AN ANGIOGUARD (801814REC/ LOT 7071244) EMBOLIC PROTECTION DEVICE WAS ADVANCED AND DEPLOYED DISTAL TO THE LESION. THE LESION WAS PRE-DILATED WITH AN AVIATOR (5 X 30) BALLOON. DURING PRE-DILATION A GRADE B DISSECTION WAS NOTED AT THE LESION. THE PHYSICIAN ATTEMPTED TO PLACE A PRECISE STENT IN THE LESION, BUT IT WOULD NOT CROSS. THEREFORE, THE PRECISE WAS REMOVED AND ANOTHER PRECISE STENT WAS PLACED AND THE LESION WAS SUCCESSFULLY TREATED. THERE WAS NO REPORTED INJURY TO THE PATIENT. THE PATIENT WAS DISCHARGED THE NEXT DAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
37469 ANGIOGUARD RX EMBOLI CAPTURE GUIDEWIRE SYSTEM EMBOLIC PROTECTION DEVICE (NTE) NTE CORDIS CORPORATION NA 70712441

Patients

Seq Age Sex Outcome Treatment
1 82 YR Hospitalization| L| R AVIATOR (5 X 30) BALLOON